Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Telehealth providers in Tennessee

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

Telehealth prescribing is allowed in Tennessee, including asynchronous care. What Tennessee requires of telehealth prescribers and pharmacies, plus listings with their verification status.

Tennessee at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Telehealth providers serving Tennessee

Bodybuilding Peptides

Sponsored

Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.

Telehealth provider · 17 products · partner lists from $172 a month · Says it serves Tennessee (not yet confirmed)

  • Prescription only, no research-use-only sales
  • Public cancellation and refund policy

We may earn a commission from these links.

Telehealth prescribing rules in Tennessee

Tennessee Code section 63-1-155 governs telehealth for licensed healthcare providers. It defines telehealth to include both real-time audio or video and store-and-forward telemedicine services, meaning asynchronous computer-based communications between provider and patient. Under section 63-1-155(b) the provider-patient relationship is not created simply by a provider receiving health information; it takes mutual consent and mutual communication. The provider is held to the same standard of practice as in person. Licensing boards may not set a stricter standard for telehealth than the practice act allows. For physicians, Board of Medical Examiners Rule 0880-02-.16(6) allows the encounter that establishes the relationship to take place by telemedicine with no facilitator present, so long as the patient uses technology that lets the physician verify identity and location, the patient transmits all relevant health information at the level of store-and-forward technology or secure video conferencing, and the physician discloses name, practice location and credentials. The rule says telemedicine is not an audio-only phone call, email, instant messaging or fax, and a patient under 18 needs a facilitator. Board Rule 0880-02-.14(7)(c) makes it a prima facie violation for a physician to prescribe based solely on answers to a set of questions, whether in person, over the Internet, or by telephone, without the history, examination, diagnosis, and treatment plan the rule requires. Both Board rules apply to physicians (MDs). The prescriber must hold a Tennessee license, and section 63-1-155 does not cover pain management clinics or chronic nonmalignant pain treatment. This record classifies asynchronous prescribing as allowed because the statute includes store-and-forward in telehealth and Rule 0880-02-.16(6) expressly lets the relationship be established with store-and-forward information, subject to the same standard of care as in person. It classifies a questionnaire alone as barred because Rule 0880-02-.14(7)(c) bars prescribing based solely on answers to a set of questions. How that bar applies inside a telemedicine encounter that meets Rule 0880-02-.16(6) is open to argument, because that rule applies notwithstanding Rule 0880-02-.14(7). [2] [3]

Compounded GLP-1 access in Tennessee

Tennessee has not adopted a looser rule, and because injectable GLP-1s are sterile preparations, a pharmacy compounding them for a Tennessee patient must also meet rule chapter 1140-07 and, if out of state, the section 63-10-216 inspection requirement. [4] [5] [7]

Research use only sellers in Tennessee

Under title 63, chapter 10, only licensed pharmacies may dispense prescription drugs to Tennessee patients, so a seller shipping "research use only" injectable peptides to Tennessee consumers is not operating under Board of Pharmacy licensure. [1] [8]

How to check a telehealth provider in Tennessee

  1. Confirm the prescriber is licensed or registered to treat patients located in Tennessee; the telehealth rules above explain what Tennessee requires. [2] [3]
  2. Ask which pharmacy will fill the prescription and check it in the Tennessee Board of Pharmacy (Tennessee Department of Health) license lookup. [1] [4] [5] [6]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Tennessee. [1] [8]

Common questions in Tennessee

Can I get a GLP-1 prescription in Tennessee through telehealth?

Yes. Section 63-1-155 lets a Tennessee-licensed provider establish a relationship and treat you by telehealth under the same standard of practice as an office visit. A live visit is not required: Board of Medical Examiners Rule 0880-02-.16(6) lets a physician establish the relationship with health information sent at the level of store-and-forward technology or secure video conferencing. A questionnaire alone is not enough. Rule 0880-02-.14(7)(c) makes it a prima facie violation for a physician to prescribe based solely on answers to a set of questions, without the history, examination, diagnosis, and treatment plan the rule requires. [2] [3]

Can a Tennessee licensing board make telehealth rules stricter than in-person rules?

No. Section 63-1-155 bars the board governing a provider from setting a more restrictive standard of practice for telehealth than the provider's practice act allows. Telehealth care is held to the same standard as in-person care, not a lower or higher one. [2]

What does an out-of-state compounding pharmacy need to ship peptides to Tennessee?

A Tennessee pharmacy license issued after the pharmacy submits an inspection by its home-state regulator from the previous 12 months, as section 63-10-216 requires. It must also report outside disciplinary actions to the Tennessee Board within 14 business days and follow Board-adopted USP compounding standards. [1] [4]

All peptide legal questions for Tennessee

Sources

  1. [1]Tennessee Board of Pharmacy (Tennessee Department of Health)
  2. [2]Tennessee Code section 63-1-155, Telehealth and telemedicine services, provider-patient relationship, standard of practice
  3. [3]Tennessee Board of Medical Examiners rules chapter 0880-02 (including Rules 0880-02-.14 and 0880-02-.16), November 2025 revision
  4. [4]Tennessee Code section 63-10-216, Compounding pharmacies
  5. [5]Rules of the Tennessee Board of Pharmacy chapter 1140-07, sterile compounding standards
  6. [6]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  7. [7]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  8. [8]21 U.S.C. 331, Prohibited acts